Shanghai Pharmaceuticals Holding Co. Ltd. Class ASSE: 601607

Announcement on the Receipt of Clinical Trial Approval Notice for a New Indication of B019

· Issued by Shanghai Pharmaceuticals Holding Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on the Receipt of Clinical Trial Approval Notice for a New Indication of B019

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis